Felix Polten

616 total citations
9 papers, 343 citations indexed

About

Felix Polten is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Felix Polten has authored 9 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Felix Polten's work include Cardiac Fibrosis and Remodeling (4 papers), Signaling Pathways in Disease (3 papers) and Peptidase Inhibition and Analysis (2 papers). Felix Polten is often cited by papers focused on Cardiac Fibrosis and Remodeling (4 papers), Signaling Pathways in Disease (3 papers) and Peptidase Inhibition and Analysis (2 papers). Felix Polten collaborates with scholars based in Germany, United States and Netherlands. Felix Polten's co-authors include Kai C. Wollert, Andreas Pich, Marc R. Reboll, Johann Bauersachs, Mortimer Korf‐Klingebiel, Hans W.M. Niessen, Hans‐Joachim Schönfeld, E Brinkmann, Tibor Kempf and Stefanie Klede and has published in prestigious journals such as Circulation, Nature Medicine and Analytical Chemistry.

In The Last Decade

Felix Polten

8 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Polten Germany 7 181 107 104 51 39 9 343
Xiaoqin Hua Germany 9 218 1.2× 133 1.2× 51 0.5× 42 0.8× 23 0.6× 26 353
Choon Boon Sim Australia 8 328 1.8× 131 1.2× 103 1.0× 64 1.3× 22 0.6× 9 487
Aleksandra Kostina Russia 12 256 1.4× 83 0.8× 140 1.3× 27 0.5× 62 1.6× 25 486
Indulekha C. L. Pillai India 4 240 1.3× 105 1.0× 138 1.3× 33 0.6× 15 0.4× 6 397
Andrea Mattiotti Netherlands 6 250 1.4× 80 0.7× 84 0.8× 18 0.4× 24 0.6× 8 361
Guosheng Xiang United States 9 264 1.5× 108 1.0× 61 0.6× 21 0.4× 18 0.5× 10 391
Mariana Valente Portugal 10 198 1.1× 157 1.5× 67 0.6× 23 0.5× 34 0.9× 18 350
Teresa Mancuso Italy 12 238 1.3× 166 1.6× 136 1.3× 63 1.2× 37 0.9× 16 486
Laura B. Jeffords United States 7 99 0.5× 76 0.7× 109 1.0× 23 0.5× 26 0.7× 10 328
Guoxing Xu China 11 304 1.7× 153 1.4× 47 0.5× 32 0.6× 41 1.1× 28 481

Countries citing papers authored by Felix Polten

Since Specialization
Citations

This map shows the geographic impact of Felix Polten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Polten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Polten more than expected).

Fields of papers citing papers by Felix Polten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Polten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Polten. The network helps show where Felix Polten may publish in the future.

Co-authorship network of co-authors of Felix Polten

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Polten. A scholar is included among the top collaborators of Felix Polten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Polten. Felix Polten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Polten, Felix, Jan Faix, Jan Hegermann, et al.. (2026). Extracellular BRICK1 drives heart repair after myocardial infarction in mice. Science Translational Medicine. 18(831). eadx2876–eadx2876.
2.
Wu, Xuekun, Marc R. Reboll, Elvira Mass, et al.. (2024). Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair. Nature Cardiovascular Research. 3(2). 186–202. 3 indexed citations
3.
Korf‐Klingebiel, Mortimer, Marc R. Reboll, Felix Polten, et al.. (2021). Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca 2+ -ATPase Expression in Cardiomyocytes. Circulation. 144(15). 1227–1240. 40 indexed citations
4.
Kropp, Kai A., Birgit Ritter, Felix Polten, et al.. (2020). Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2. Viruses. 12(12). 1428–1428. 6 indexed citations
5.
Halloin, Caroline, Kristin Schwanke, Annika Franke, et al.. (2019). Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture. Stem Cell Reports. 13(2). 366–379. 72 indexed citations
6.
Polten, Felix, Marc R. Reboll, Christian Widera, et al.. (2018). Plasma Concentrations of Myeloid-Derived Growth Factor in Healthy Individuals and Patients with Acute Myocardial Infarction as Assessed by Multiple Reaction Monitoring-Mass Spectrometry. Analytical Chemistry. 91(2). 1302–1308. 14 indexed citations
7.
8.
Reboll, Marc R., Mortimer Korf‐Klingebiel, Stefanie Klede, et al.. (2017). EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow–Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction. Circulation. 136(19). 1809–1823. 35 indexed citations
9.
Korf‐Klingebiel, Mortimer, Marc R. Reboll, Stefanie Klede, et al.. (2015). Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nature Medicine. 21(2). 140–149. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026